Skip to Content
Merck
CN

533734

1,3-Propanediol

≥99.6%

Synonym(s):

1,3-Dihydroxypropane, Trimethylene glycol

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Linear Formula:
HO(CH2)3OH
CAS Number:
504-63-2
Molecular Weight:
76.09
EC Number:
207-997-3
UNSPSC Code:
12162002
PubChem Substance ID:
24877990
Beilstein/REAXYS Number:
969155
MDL number:
MFCD00002949

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

InChI key

YPFDHNVEDLHUCE-UHFFFAOYSA-N

InChI

1S/C3H8O2/c4-2-1-3-5/h4-5H,1-3H2

SMILES string

OCCCO[H]

vapor pressure

0.8 mmHg ( 20 °C), 9.8 mmHg ( 100 °C)

assay

≥99.6%

impurities

<0.1% water

surface tension

46.2 dyn/cm, 20 °C

viscosity

52 cP(20 °C)(lit.)

bp

214 °C/760 mmHg (lit.)

mp

−27 °C (lit.)

solubility

H2O: soluble

density

1.053 g/mL at 25 °C (lit.)

anion traces

chloride (Cl-): <0.5 ppm

Looking for similar products? Visit Product Comparison Guide

Application

For applications, see P5040-4

Storage Class

10 - Combustible liquids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves

Regulatory Information

新产品
This item has

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
01930DJ
06611LE
00731TB
11528TO
04206JI

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Ryosuke Kikuchi et al.
Nature medicine, 20(12), 1464-1471 (2014-11-05)
Peripheral artery disease (PAD) generates tissue ischemia through arterial occlusions and insufficient collateral vessel formation. Vascular insufficiency in PAD occurs despite higher circulating levels of vascular endothelial growth factor A (VEGF-A), a key regulator of angiogenesis. Here we show that
Charles E Nakamura et al.
Current opinion in biotechnology, 14(5), 454-459 (2003-10-29)
Improvements in the biological production of 1,3-propanediol, a key component of an emerging polymer business, have been realized. Utilizing genes from natural strains that produce 1,3-propanediol from glycerol, metabolic engineering has enabled the development of a recombinant strain that utilizes
E Celińska
Biotechnology advances, 28(4), 519-530 (2010-04-07)
The history of 1,3-propanediol (1,3-PD) conversion from being a specialty chemical to being a bulk chemical illustrates that the concerted effort of different metabolic engineering approaches brings the most successful results. In order to metabolically tailor the 1,3-PD production pathway
Sarbjit S Saini et al.
The Journal of investigative dermatology, 135(1), 67-75 (2014-07-22)
ASTERIA I was a 40-week, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of subcutaneous omalizumab as add-on therapy for 24 weeks in patients with chronic idiopathic urticaria/spontaneous urticaria (CIU/CSU) who remained symptomatic despite H1 antihistamine treatment at
R K Saxena et al.
Biotechnology advances, 27(6), 895-913 (2009-08-12)
1,3-Propanediol, a valuable bifunctional molecule, can be produced from renewable resources using microorganisms. It has several promising properties for many synthetic reactions, particularly for polymer and cosmetic industries. By virtue of being a natural product, relevant biochemical pathways can be
View All Related Papers

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service